Baird Downgrades Voyager Therapeutics (VYGR) to Neutral
Tweet
Share
E-mailGet Alerts VYGR Hot Sheet
Price: $7.51 -0.53%
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Baird analyst Brian Skorney downgraded Voyager Therapeutics (NASDAQ: VYGR) from Outperform to Neutral with a price target of $6.00.
For an analyst ratings summary and ratings history on Voyager Therapeutics click here. For more ratings news on Voyager Therapeutics click here.
Shares of Voyager Therapeutics closed at $6.23 yesterday.
You May Also Be Interested In
- HSBC Downgrades Feng Tay Enterprises (9910:TT) to Hold
- Voyager Therapeutics (VYGR) Picks Development Candidate for GBA1 Program
- HSBC Downgrades Harmony Gold Mining (HAR:SJ) (HMY) to Reduce
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
